Treatment Patterns in Psoriatic Arthritis Patients Newly Initiated On Non-Biologic Disease-Modifying Anti-Rheumatic Drugs.

被引：0
|
作者：
Curtis, Jeffrey [1 ]
Gauthier, Genevieve [2 ]
Hiscock, Robert [2 ]
Zhang, Frank [3 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Anal Grp Inc, Montreal, PQ, Canada
[3] Celgene Corp, Warren, NJ USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1840
引用
收藏
页码：S782 / S783
页数：2
相关论文
共 50 条
  • [1] TREATMENT PATTERNS IN PSORIATIC ARTHRITIS (PSA) PATIENTS NEWLY INITIATED ON NON-BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS)
    Curtis, J.
    Gauthier, G.
    Hiscock, R.
    Zhang, F.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A517 - A517
  • [2] TREATMENT PATTERNS IN PSORIATIC ARTHRITIS (PSA) PATIENTS NEWLY INITIATED ON ORAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS)
    Zhang, F.
    Guerin, A.
    Gauthier, G.
    Curtis, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 108 - 108
  • [3] Healthcare Costs in Psoriatic Arthritis Patients Newly Initiated On a Biologic Disease-Modifying Anti-Rheumatic Drug or Methotrexate.
    Zhang, Frank
    Hiscock, Robert
    Curtis, Jeffrey
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S780 - S780
  • [4] IMPACT OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN LIPID PROFILE OF PSORIATIC ARTHRITIS PATIENTS
    Guajardo-Aldaco, Andrea L.
    Galarza-Delgado, Dionicio A.
    Azpiri-Lopez, Jose R.
    Colunga-Pedraza, Iris J.
    Cardenas-de la Garza, Jesus A.
    Arvizu-Rivera, Rosa I.
    Elizondo-Benitez, Maria F.
    Gonzalez-Gonzalez, Valeria
    [J]. ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [5] Cardiovascular Risk of Synthetic, Non-Biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
    Mourouzis, Iordanis S.
    Manolis, Antonis S.
    Pantos, Constantinos
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2020, 18 (05) : 455 - 462
  • [6] Treatment patterns in psoriatic arthritis patients newly initiated on oral nonbiologic or biologic disease-modifying antirheumatic drugs
    Zhang, Huabin F.
    Gauthier, Genevieve
    Hiscock, Robert
    Curtis, Jeffrey R.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2014, 16 (04)
  • [7] Treatment patterns in psoriatic arthritis patients newly initiated on oral nonbiologic or biologic disease-modifying antirheumatic drugs
    Huabin F Zhang
    Geneviève Gauthier
    Robert Hiscock
    Jeffrey R Curtis
    [J]. Arthritis Research & Therapy, 16
  • [8] BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs
    Ledingham, Jo
    Gullick, Nicola
    Irving, Katherine
    Gorodkin, Rachel
    Aris, Melissa
    Burke, Jean
    Gordon, Patrick
    Christidis, Dimitrios
    Galloway, Sarah
    Hayes, Eranga
    Jeffries, Andrew
    Mercer, Scott
    Mooney, Janice
    van Leuven, Sander
    Galloway, James
    [J]. RHEUMATOLOGY, 2017, 56 (06) : 865 - 868
  • [9] Characteristics of rheumatoid arthritis patients initiating therapy with abatacept, other biologics, and non-biologic disease-modifying anti-rheumatic drugs
    Hoffman, Veena
    Simon, Teresa A.
    Liu, Nan
    Lin, Nancy D.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 278 - 278
  • [10] Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Choy, Ernest
    Aletaha, Daniel
    Behrens, Frank
    Finckh, Axel
    Gomez-Reino, Juan
    Gottenberg, Jacques-Eric
    Schuch, Florian
    Rubbert-Roth, Andrea
    [J]. RHEUMATOLOGY, 2017, 56 (05) : 689 - 697
12345